Literature DB >> 18046484

Apoptotic and autophagic responses to Bcl-2 inhibition and photodamage.

David Kessel1, Adelaida Segarra Arroyo.   

Abstract

Among the cellular responses to photodamage initiated by photodynamic therapy (PDT) are autophagy and apoptosis. While autophagy is a reversible process that can be both a survival and a death pathway, apoptosis is irreversible, leading only to cell death. In this study, we followed the fate of mouse leukemia L1210 cells after photodamage to the endoplasmic reticulum (ER) using a porphycene photosensitizer, where Bcl-2 was among the PDT targets. In wild-type cells, we observed a rapid wave of autophagy, presumed to represent the recycling of some damaged organelles, followed by apoptosis. Using shRNA technology, we created a Bax knockdown line (L1210/Bax(-)). In the latter cell line, we found a marked decrease in apoptosis after photodamage or pharmacologic inactivation of Bcl-2 function, but this did not affect PDT efficacy. Loss of viability was associated with a highly-vacuolated morphology consistent with autophagic cell death. Previous studies indicated pro-survival attributes of autophagy after low-dose PDT, suggesting that autophagy may be responsible for the 'shoulder' on the dose-response curve. It appears that attempts at extensive recycling of damaged organelles are associated with cell death, and that this phenomenon is amplified when apoptosis is suppressed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046484      PMCID: PMC2768724          DOI: 10.1039/b707953b

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  22 in total

Review 1.  Autophagy: molecular machinery for self-eating.

Authors:  T Yorimitsu; D J Klionsky
Journal:  Cell Death Differ       Date:  2005-11       Impact factor: 15.828

2.  Photodynamic therapy-induced death of HCT 116 cells: Apoptosis with or without Bax expression.

Authors:  S-M Chiu; L-Y Xue; K Azizuddin; N L Oleinick
Journal:  Apoptosis       Date:  2005-12       Impact factor: 4.677

Review 3.  Autophagy in cell death: an innocent convict?

Authors:  Beth Levine; Junying Yuan
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1.

Authors:  David Kessel; John J Reiners
Journal:  Cancer Lett       Date:  2006-10-19       Impact factor: 8.679

Review 5.  Autophagy and cell death.

Authors:  Devrim Gozuacik; Adi Kimchi
Journal:  Curr Top Dev Biol       Date:  2007       Impact factor: 4.897

Review 6.  Bcl-2 inhibition of autophagy: a new route to cancer?

Authors:  Sophie Pattingre; Beth Levine
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

7.  Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay.

Authors:  S X Cai; H Z Zhang; J Guastella; J Drewe; W Yang; E Weber
Journal:  Bioorg Med Chem Lett       Date:  2001-01-08       Impact factor: 2.823

8.  Apoptosis and autophagy after mitochondrial or endoplasmic reticulum photodamage.

Authors:  David Kessel; John J Reiners
Journal:  Photochem Photobiol       Date:  2007 Sep-Oct       Impact factor: 3.421

9.  Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy.

Authors:  Esther Buytaert; Geert Callewaert; Nico Hendrickx; Luca Scorrano; Dieter Hartmann; Ludwig Missiaen; Jackie R Vandenheede; Ingeborg Heirman; Johan Grooten; Patrizia Agostinis
Journal:  FASEB J       Date:  2006-02-02       Impact factor: 5.191

10.  Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy.

Authors:  S-M Chiu; L-Y Xue; J Usuda; K Azizuddin; N L Oleinick
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

View more
  27 in total

1.  Light-Activated Pharmaceuticals: Mechanisms and Detection.

Authors:  David Kessel; John Reiners
Journal:  Isr J Chem       Date:  2012-09-01       Impact factor: 3.333

2.  Adventures in photodynamic therapy: 1976-2008.

Authors:  David Kessel
Journal:  J Porphyr Phthalocyanines       Date:  2008-07-24       Impact factor: 1.811

3.  Promotion of PDT efficacy by a Bcl-2 antagonist.

Authors:  David Kessel
Journal:  Photochem Photobiol       Date:  2007-12-20       Impact factor: 3.421

4.  Autophagy modification augmented the treatment effects initiated by arsenic trioxide in NB4 cells.

Authors:  YaLi Ren; YanLing Xie; LiJun Chai; ShuHe Wang; Ming Cheng
Journal:  Med Oncol       Date:  2010-01-27       Impact factor: 3.064

Review 5.  Chemosensitization of prostate cancer by modulating Bcl-2 family proteins.

Authors:  David Karnak; Liang Xu
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

6.  Effects of HPV Status on Responsiveness to Ionizing Radiation vs Photodynamic Therapy in Head and Neck Cancer Cell lines.

Authors:  David Kessel; Won Jin Cho; Joseph Rakowski; Harold E Kim; Hyeong-Reh C Kim
Journal:  Photochem Photobiol       Date:  2019-10-10       Impact factor: 3.421

Review 7.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

8.  Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy.

Authors:  Liang-Yan Xue; Song-Mao Chiu; Nancy L Oleinick
Journal:  Autophagy       Date:  2010-03-02       Impact factor: 16.016

9.  Initiation of autophagy by photodynamic therapy.

Authors:  David Kessel; Nancy L Oleinick
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

10.  PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.

Authors:  Imran Rizvi; Sriram Anbil; Nermina Alagic; Jonathan Celli; Jonathan P Celli; Lei Zak Zheng; Akilan Palanisami; Michael D Glidden; Brian W Pogue; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2013-04-04       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.